药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Glucosamine
Yellow Fever Vaccine
The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Ponatinib.
Glucosamine
Bacillus calmette-guerin substrain connaught live antigen
The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Ponatinib.
Glucosamine
Bacillus calmette-guerin substrain tice live antigen
The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Ponatinib.
Glucosamine
Varicella Zoster Vaccine (Live/attenuated)
The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Ponatinib.
Glucosamine
Rubella virus vaccine
The risk or severity of infection can be increased when Rubella virus vaccine is combined with Ponatinib.
Glucosamine
Lipegfilgrastim
Ponatinib may increase the myelosuppressive activities of Lipegfilgrastim.
Glucosamine
Pitolisant
The serum concentration of Ponatinib can be decreased when it is combined with Pitolisant.
Glucosamine
Betrixaban
The serum concentration of Betrixaban can be increased when it is combined with Ponatinib.
Glucosamine
Naftopidil
The risk or severity of bleeding can be increased when Naftopidil is combined with Ponatinib.
Glucosamine
Tranilast
The risk or severity of bleeding can be increased when Tranilast is combined with Ponatinib.
Glucosamine
Nimesulide
The risk or severity of bleeding can be increased when Nimesulide is combined with Ponatinib.
Glucosamine
Relcovaptan
The risk or severity of bleeding can be increased when Relcovaptan is combined with Ponatinib.
Glucosamine
Buflomedil
The risk or severity of bleeding can be increased when Buflomedil is combined with Ponatinib.
Glucosamine
Linsidomine
The risk or severity of bleeding can be increased when Linsidomine is combined with Ponatinib.
Glucosamine
Cloricromen
The risk or severity of bleeding can be increased when Cloricromen is combined with Ponatinib.
Glucosamine
Picotamide
The risk or severity of bleeding can be increased when Picotamide is combined with Ponatinib.
Glucosamine
Ramatroban
The risk or severity of bleeding can be increased when Ramatroban is combined with Ponatinib.
Glucosamine
Hydroxytyrosol
The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Ponatinib.
Glucosamine
Butylphthalide
The risk or severity of bleeding can be increased when Butylphthalide is combined with Ponatinib.
Glucosamine
Indobufen
The risk or severity of bleeding can be increased when Indobufen is combined with Ponatinib.